Literature DB >> 9472776

Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.

T Yoshimatsu1, M Tamura, S Kuriyama, K Ikenaka.   

Abstract

To obtain high-titer recombinant retroviruses, we constructed plasmid pDL+, which carries the extended Psi region and the polyomavirus early region, including the replication origin and the early gene. Although pDL+ is useful for obtaining high-titer recombinant retroviruses, this vector plasmid is difficult to modify further for tissue-specific expression of foreign genes. To overcome this problem, the coding region of the polyomavirus early gene was expressed in the packaging cell lines. We modified the packaging cell lines, psi2 and PA317, by stably introducing the polyomavirus early gene, and established psiMP34 and psiMP37 from psi2, and PAMP51 from PA317. In the transient expression system using plasmids with and without the polyomavirus replication origin, the titers of recombinant retrovirus produced by these cell lines were 10-100 times higher than produced by the parent cell line and reached levels of 0.5-1.5 x 106 cfu/ml. Expression of the polyomavirus early gene in the packaging cell lines did not stimulate the production of replication-competent retrovirus. We also routinely established stable clones producing retrovirus titers over 1 x 10(7) cfu/ml from psiMP34 and PAMP51. We found that the activity of the long terminal repeat (LTR) promoter is stimulated by the polyomavirus early region protein(s) in these cell lines. Therefore, increases titer can be expected to occur in all the retroviral vectors in which LTR promoter is used to transcribe the retroviral genome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472776     DOI: 10.1089/hum.1998.9.2-161

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  6 in total

1.  Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

Authors:  T Ohtsuka; M Ishibashi; G Gradwohl; S Nakanishi; F Guillemot; R Kageyama
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  Creation and characterization of temperature-sensitive CENP-C mutants in vertebrate cells.

Authors:  T Fukagawa; V Regnier; T Ikemura
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

3.  Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.

Authors:  Toshio Yawata; Yusuke Maeda; Makiko Okiku; Eri Ishida; Kazuhiro Ikenaka; Keiji Shimizu
Journal:  J Neurooncol       Date:  2011-02-24       Impact factor: 4.130

4.  The basic helix-loop-helix gene hesr2 promotes gliogenesis in mouse retina.

Authors:  T Satow; S K Bae; T Inoue; C Inoue; G Miyoshi; K Tomita; Y Bessho; N Hashimoto; R Kageyama
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  Selective transduction of HIV-1-infected cells by the combination of HIV and MMLV vectors.

Authors:  Noriyasu Sakai; Koichi Miyake; Noriko Suzuki; Takashi Shimada
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

6.  Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor.

Authors:  M Yamada; M Jung; K Tetsushi; A Ivanova; K A Nave; K Ikenaka
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.